Ziyuan Nie

Shijiazhuang, 050000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

AURKC Promotes Clear Cell Renal Cell Carcinoma Proliferation Through Upregulation of ERp57.

AURKC Promotes Clear Cell Renal Cell Carcinoma Proliferation Through Upregulation of ERp57.

Journal: Journal of Cancer

Published: September 02, 2024

Regulatory role of RBM39 in acute myeloid leukemia: Mediation through the PI3K/AKT pathway.

Regulatory role of RBM39 in acute myeloid leukemia: Mediation through the PI3K/AKT pathway.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: August 20, 2023

The histone deacetylase inhibitor chidamide improve the sensitivity of chronic myelogenous leukemia drug-resistant cells to imatinib by regulating PTPN6.

The histone deacetylase inhibitor chidamide improve the sensitivity of chronic myelogenous leukemia drug-resistant cells to imatinib by regulating PTPN6.

Journal: Minerva medica

Published: May 18, 2023

SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling.

SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling.

Journal: Journal of translational medicine

Published: February 23, 2022

Corrigendum to "Salvia miltiorrhiza bunge exerts anti-oxidative effects through inhibiting KLF10 expression in vascular smooth muscle cells exposed to high glucose" [J. Ethnopharmacol. 262 (2020) 113208].

Corrigendum to "Salvia miltiorrhiza bunge exerts anti-oxidative effects through inhibiting KLF10 expression in vascular smooth muscle cells exposed to high glucose" [J. Ethnopharmacol. 262 (2020) 113208].

Journal: Journal of ethnopharmacology

Published: July 02, 2021

HNRNPH1 Is a Novel Regulator Of Cellular Proliferation and Disease Progression in Chronic Myeloid Leukemia.

HNRNPH1 Is a Novel Regulator Of Cellular Proliferation and Disease Progression in Chronic Myeloid Leukemia.

Journal: Frontiers in oncology

Published: March 19, 2021

Daratumumab combining with venetoclax, three-day multi-frequency decitabine, vincristine, dexamethasone (VDVD) as the salvage treatment of relapsed/refractory T-cell acute lymphoblastic leukemia.

Daratumumab combining with venetoclax, three-day multi-frequency decitabine, vincristine, dexamethasone (VDVD) as the salvage treatment of relapsed/refractory T-cell acute lymphoblastic leukemia.

Journal: Haematologica

Published: September 10, 2020

Salvia miltiorrhiza bunge exerts anti-oxidative effects through inhibiting KLF10 expression in vascular smooth muscle cells exposed to high glucose.

Salvia miltiorrhiza bunge exerts anti-oxidative effects through inhibiting KLF10 expression in vascular smooth muscle cells exposed to high glucose.

Journal: Journal of ethnopharmacology

Published: April 07, 2020

Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21.

Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 17, 2018

Research on the epigenetic regulation mechanism of the PTPN6 gene in advanced chronic myeloid leukaemia.

Research on the epigenetic regulation mechanism of the PTPN6 gene in advanced chronic myeloid leukaemia.

Journal: British journal of haematology

Published: November 14, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026